SEC Form 4 · accession 0001209191-15-054354
AGIOS PHARMACEUTICALS, INC. · AGIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Maraganore
Director
Period of report
Jun 15, 2015
Accepted (ET)
Jun 17, 2015 · 6:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Jun 15, 2015 | G | 410 | $0.00 | D | 49,764 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects a gift of shares from the reporting person to Massachusetts Institute of Technology.